Monitor the class action mediation outcome (through Nov 10, 2026) — a large settlement or adverse ruling would be existential for this $12M market cap company. Watch for the next capital raise; the ~$12M cash provides roughly 12-14 months runway at H1 2026 burn rate, but massive warrant overhang suggests continued dilution. Revenue growth trajectory (45% YoY) is positive, but not remotely profitable — short sellers may target the going-concern and litigation risk.
Price Chart
Executive Summary
IceCure Medical filed H1 2026 results showing 45% YoY revenue growth to $1.8M and improving gross margin to 30%, but net loss widened 26% to $8.8M and operating cash burn increased to $8.1M. The company disclosed a certified class action seeking ~$133.6M in damages, a going-concern warning (accumulated deficit of $129.2M, cash of $12M insufficient for 12 months), and massive warrant dilution: 3.7M exercisable warrants plus 1.2M post-period pre-funded warrant exercises. The combination of revenue growth with escalating losses, litigation overhang, and dilutive overhang creates a mixed signal — commercial progress cannot sustain the company without additional capital.
Key Facts
- Revenue of $1.8M for H1 2026 vs $1.3M in H1 2025, +45% YoY; US revenue $608K vs $371K, +64% YoY
- Net loss of $8.8M widened 26% from $7.0M in prior year; operating cash burn -$8.1M vs -$6.9M
- Cash and cash equivalents of $12.0M at June 30, 2026, up from $8.9M at Dec 31, 2025
- Going-concern raised: accumulated deficit of $129.2M; cash not sufficient for 12 months; needs additional funding
- Class action certified on May 5, 2026; amended complaint seeks approximately NIS 397,875 thousand (~$133.6M); mediation through Nov 10, 2026
- Massive warrant overhang: ~3.7M exercisable warrants at $3.00-$30.00 strike, plus 1,833,334 pre-funded warrants; post-period 1,204,334 pre-funded warrants exercised adding 1.2M shares
- Gross margin improved to 30% from 28% in prior year period
Financial Impact
Revenue grew ~$568K or 45% YoY; net loss worsened by ~$1.8M; financing proceeds of ~$8.5M in Q2 provide ~12 months of cash at current burn rate, but litigation exposure of up to ~$133.6M represents 11x current market cap
Risk Factors
- Going-concern risk: cash insufficient for 12 months; requires additional capital with uncertain terms
- Class action litigation seeking ~$133.6M in damages — potential settlement or adverse outcome could be existential
- Massive warrant overhang: ~3.7M exercisable warrants at $3.00-$30.00 per share plus remaining ~629K pre-funded warrants
- Increasing cash burn: operating cash flow -$8.1M in H1 2026 vs -$6.9M in H1 2025, 17% increase
- Nasdaq continued listing risk (reverse split effected June 2026 implies compliance concerns)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (ICCM) — Batch item 1 | 0001213900-26-088071 |
| Document: ea030128701ex99-2.htm | 0001213900-26-088071 |
| Document: ea0301287-6k_icecure.htm | 0001213900-26-088071 |
| Document: ea030128701ex99-3.htm | 0001213900-26-088071 |
| Document: 0001213900-26-088071-index-headers.html | 0001213900-26-088071 |
| Document: 0001213900-26-088071-index.html | 0001213900-26-088071 |
| Document: 0001213900-26-088071.txt | 0001213900-26-088071 |
| 6-K Filing (ICCM) — Batch item 8 | 0001213900-26-088071 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.10 | awaiting T+60 | — | $1.01 (−8.18%) |
Oct 5, 2026 21d ago | 6-K | $1.27 | awaiting T+60 | — | $1.01 (−20.47%) |
Oct 5, 2026 21d ago | 6-K | $1.54 | awaiting T+60 | — | $1.01 (+34.42%) |
Sep 10, 2026 6w ago | 6-K | $2.14 | awaiting T+60 | — | $1.01 (−52.80%) |
Aug 24, 2026 9w ago | 6-K | $2.27 | awaiting T+60 | — | $1.01 (−55.51%) |
Aug 19, 2026 9w ago | EFFECT | $2.52 | awaiting T+60 | — | $1.01 (+59.92%) |
Aug 14, 2026 10w ago | 6-K | $2.82 | awaiting T+60 | — | $1.01 (−64.18%) |
Aug 12, 2026 10w ago | 6-K | $3.11 | awaiting T+60 | — | $1.01 (−67.47%) |
Jul 6, 2026 16w ago | EFFECT | $4.61 $1.59 | ▲ +65.51% | ▲ +67.23% | $1.01 (+78.09%) |
Jun 26, 2026 17w ago | 6-K | $5.26 $1.95 | ▲ +62.93% | ▲ +67.31% | $1.01 (+80.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers